{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-020829","form_type":"8-K","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2022-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.677398+00:00","generated_at":"2026-06-22T19:18:24.908394+00:00","sec_items":["2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Marpai closes acquisition of Maestro Health, doubling its size in self-funded TPA market","bullets":["Acquisition closed Oct 31, 2022, doubles Marpai's customer and member count.","Maestro serves over 80 self-insured employers; combined company covers over 40,000 employees.","Maestro adds clinical care management and pharmacy cost containment saving up to 75% on specialty meds.","Integration of Maestro brand and systems expected by early 2023.","Marpai CEO expects acquisition to transform cost and outcome curves in self-funded healthcare."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-020829","json":"https://secwatch.observer/filing/0000950170-22-020829.json","markdown":"https://secwatch.observer/filing/0000950170-22-020829.md","text":"https://secwatch.observer/filing/0000950170-22-020829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/0000950170-22-020829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/mrai-20221101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T19:18:24.908394+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"92734a0b85fc3f6758a48bcc874009466a38e104","claim":"Marpai, Inc. completed an acquisition involving Maestro Health, LLC (closed 2022-10-31).","evidence_excerpt":"On October 31, 2022, Marpai, Inc. (the “Company”) consummated the previously announced acquisition (the “Acquisition”) of Maestro Health, LLC (“Maestro Health”), a Delaware limited liability company, pursuant to the terms of the Membership Interest Purchase Agreement executed by and among the Company, X.L. America, Inc., a Delaware corporation, Seaview Re Holdings Inc., a Delaware corporation, and AXA S.A., a French société anonyme.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844392/000095017022020829/0000950170-22-020829-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Maestro Health, LLC"},{"label":"Closing","value":"2022-10-31"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}